update on tirzepatide Week 19 20 weeks off tirzepatide -

Slow the emptying of food from the stomach

Average weight loss on the 2.4mg strength injection suggests average weight loss of around 15%, and this is similar for the full strength of the oral pill

Mechanisms hypothesised to underlie blood pressure reduction with tirzepatide include: Weight reduction : Loss of adipose tissue decreases sympathetic nervous system activity, reduces cardiac output, and improves insulin sensitivityall contributing to lower blood pressure Natriuresis : GLP-1 receptor activation may promote sodium excretion through renal effects, though direct evidence for tirzepatide is limited [10] Improved endothelial function : Weight loss and metabolic improvements may enhance vascular health Reduced inflammation : Adipose tissue reduction decreases pro-inflammatory cytokines that may contribute to hypertension It is important to note that whilst the blood pressure reductions are consistent across trials, tirzepatide is not licensed as an antihypertensive agent

By understanding the nuances of semaglutide treatment, individuals can optimize their health outcomes while minimizing adverse events

Hydroxyl radical The reactivity of O and H 2 O 2 are significantly lower than that of OH